These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 30145513

  • 1. The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.
    Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry PP, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH.
    J Affect Disord; 2018 Dec 01; 241():425-432. PubMed ID: 30145513
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.
    Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, Salzman PM, McQuade RD, Nyilas M, Carson WH.
    J Clin Psychiatry; 2017 Mar 01; 78(3):324-331. PubMed ID: 28146613
    [Abstract] [Full Text] [Related]

  • 3. Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder.
    Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH.
    J Affect Disord; 2018 Feb 01; 227():649-656. PubMed ID: 29174738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia.
    Fleischhacker WW, Sanchez R, Johnson B, Jin N, Forbes RA, McQuade R, Baker RA, Carson W, Kane JM.
    Int Clin Psychopharmacol; 2013 Jul 01; 28(4):171-6. PubMed ID: 23615694
    [Abstract] [Full Text] [Related]

  • 9. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
    McIntyre RS.
    Clin Ther; 2010 Jul 01; 32 Suppl 1():S32-8. PubMed ID: 20152551
    [Abstract] [Full Text] [Related]

  • 10. Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.
    Potkin SG, Preda A.
    Expert Opin Pharmacother; 2016 Jul 01; 17(3):395-407. PubMed ID: 26864352
    [Abstract] [Full Text] [Related]

  • 11. Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study.
    Correll CU, Kohegyi E, Zhao C, Baker RA, McQuade R, Salzman PM, Sanchez R, Nyilas M, Carson W.
    J Am Acad Child Adolesc Psychiatry; 2017 Sep 01; 56(9):784-792. PubMed ID: 28838583
    [Abstract] [Full Text] [Related]

  • 12. Initiation of aripiprazole once-monthly in patients with schizophrenia.
    Raoufinia A, Baker RA, Eramo A, Nylander AG, Landsberg W, Kostic D, Larsen F.
    Curr Med Res Opin; 2015 Mar 01; 31(3):583-92. PubMed ID: 25586294
    [Abstract] [Full Text] [Related]

  • 13. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG, Raoufinia A, Mallikaarjun S, Bricmont P, Peters-Strickland T, Kasper W, Baker RA, Eramo A, Sanchez R, McQuade R.
    Curr Med Res Opin; 2013 Oct 01; 29(10):1241-51. PubMed ID: 23822566
    [Abstract] [Full Text] [Related]

  • 14. Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.
    Calabrese JR, Jin N, Johnson B, Such P, Baker RA, Madera J, Hertel P, Ottinger J, Amatniek J, Kawasaki H.
    Int J Bipolar Disord; 2018 Jun 10; 6(1):14. PubMed ID: 29886522
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
    Findling RL, Youngstrom EA, McNamara NK, Stansbrey RJ, Wynbrandt JL, Adegbite C, Rowles BM, Demeter CA, Frazier TW, Calabrese JR.
    J Clin Psychiatry; 2012 Jan 10; 73(1):57-63. PubMed ID: 22152402
    [Abstract] [Full Text] [Related]

  • 16. Drug safety evaluation of aripiprazole in bipolar disorder.
    Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A.
    Expert Opin Drug Saf; 2019 Jun 10; 18(6):455-463. PubMed ID: 31072228
    [Abstract] [Full Text] [Related]

  • 17. Aripiprazole IM depot as an option for the treatment of bipolar disorder.
    Kotzalidis GD, Rapinesi C, Chetoni C, De Filippis S.
    Expert Opin Pharmacother; 2021 Aug 10; 22(11):1407-1416. PubMed ID: 33847183
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study.
    Xiao L, Zhao Q, Li AN, Sun J, Wu B, Wang L, Zhang H, Zhang R, Li K, Xu X, Liu T, Zhang W, Xie S, Xu X, Tan Y, Zhang K, Zhang H, Guan N, Xian M, Uki M, Wang G.
    Psychopharmacology (Berl); 2022 Jan 10; 239(1):243-251. PubMed ID: 34989824
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study.
    Muzina DJ, Momah C, Eudicone JM, Pikalov A, McQuade RD, Marcus RN, Sanchez R, Carlson BX.
    Int J Clin Pract; 2008 May 10; 62(5):679-87. PubMed ID: 18373615
    [Abstract] [Full Text] [Related]

  • 20. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L, Estrada G, Oudovenko N, Vieta E.
    BMC Psychiatry; 2017 Apr 04; 17(1):126. PubMed ID: 28376877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.